Results 101 to 110 of about 1,862 (162)

Higher glymphatic system activity is linked to longer prodromal stage in isolated REM sleep behavior disorder: a possible protective factor. [PDF]

NPJ Parkinsons Dis
Rottova V, Marecek S, Krajca T, Keller J, Sonka K, Dusek P, Nepozitek J.   +6 more
europepmc   +1 more source

Epigenetic ageing and the risk of Parkinson's disease. [PDF]

J Neurol Neurosurg Psychiatry
Peng X, Flores-Torres MH, Cortese M, Peng C, Hung AY, Schwarzschild M, Ascherio A, Bjornevik K.   +7 more
europepmc   +1 more source

Response to “Methodological Considerations on CYP2D6 Phenoconversion Due to Drug‐Drug Interaction” [PDF]

Clinical Pharmacology & Therapeutics, 2019
Kelsey, West, Andrew A, Monte
openaire   +2 more sources

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum. [PDF]

Eur J Nucl Med Mol Imaging
Arnaldi D, Mattioli P, Orso B, Raffa S, Lanfranchi F, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Montini A, Mayà G, Muñoz-Lopetegi A, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, De Verbizier D, Plazzi G, Antelmi E, Pizza F, Terzaghi M, Bossert I, Kulcsárová K, Garibotto V, Nicastro N, Lathuilière A, Bonanni L, Morbelli S, Roascio M, Arnulfo G, Pardini M.   +49 more
europepmc   +1 more source

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

Schizophr Bull
Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB.   +14 more
europepmc   +1 more source

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study. [PDF]

Pharmacogenomics J
Görnert C, Scherf-Clavel M, Weber H, Roll SC, Eckert A, Reif A, Hahn M.   +6 more
europepmc   +1 more source

Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles. [PDF]

Clin Transl Sci
Bennett MH, Poweleit EA, Vaughn SE, Retke B, Toren P, Strawn JR, Ramsey LB.   +6 more
europepmc   +1 more source

Cholinergic degeneration in prodromal and early Parkinson's disease: a link to present and future disease states. [PDF]

Brain
Eisenstein T, Groenewald K, van Hillegondsberg L, Al Hajraf F, Zerenner T, Lawton MA, Ben-Shlomo Y, Griffanti L, Hu MT, Klein JC.   +9 more
europepmc   +1 more source

Design considerations for C9orf72 disease prevention trials. [PDF]

Brain
Benatar M, Staffaroni AM, Wuu J, McDermott MP, Quintana M, Swidler J, Andersen G, Huey ED, Turner MR, Macklin EA, Berry JD, McMillan CT, Gendron T, Onyike C, Rosen H, Heuer HW, Grignon AL, Dave KD, Balas C, Gleixner A, Satlin A, Dunn B, Dacks P, Boxer AL.   +23 more
europepmc   +1 more source

Blood will tell: plasma biomarkers in isolated REM sleep behavior disorder. [PDF]

Sleep
Ibrahim A, Süzgün MA, Stefani A.
europepmc   +1 more source